Vir Bio's Cancer Treatment Progress Driving Shares Hight
Vir Biotechnology Vir is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. The company on Monday announced new data from the ongoing Phase 1 clini ...Show more
Introducing: Bloomberg This Weekend
'Bloomberg This Weekend' features unique conversations on business, news, lifestyle and culture. Join David Gura, Christina Ruffini and Lisa Mateo Saturdays and Sundays for discussions with business leaders, lawmakers and cultural icons. Watch the show LIVE on Bloomberg Televisio ...Show more
Sonali Basak, Bloomberg Wall Street Reporter, discusses Wall Street bank earnings. She spoke with hosts Bryan Curtis and Rishaad Salamat on "Bloomberg Daybreak Asia."